Achieve Life Sciences (ACHV) Prepaid Assets (2010 - 2026)
Achieve Life Sciences (ACHV) posted Prepaid Assets of $125000.0 for Q1 2026, down 35.23% on a QoQ basis from $193000.0 in Q4 2025, and down 92.88% year-over-year from $1.8 million in Q1 2025.
Achieve Life Sciences (ACHV) Prepaid Assets (2010 - 2026) Analysis & Trends
Achieve Life Sciences' Prepaid Assets history runs 17 years deep, the most recent figure standing at $125000.0 for Q1 2026.
- Quarterly Prepaid Assets fell 92.88% year-over-year to $125000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125000.0 (down 92.88% YoY) and the FY2025 annual result came in at $193000.0, down 90.84% from the prior year.
- Prepaid Assets was $125000.0 for Q1 2026 at Achieve Life Sciences, down from $193000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $2.6 million in Q3 2024 and bottomed at $125000.0 in Q1 2026.
- A 5-year average of $1.6 million and a median of $1.5 million in 2025 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 238.84% — and 2026, when it slumped 92.88%.
- Achieve Life Sciences' Prepaid Assets stood at $2.5 million in 2022, then slumped by 46.01% to $1.3 million in 2023, then soared by 59.02% to $2.1 million in 2024, then slumped by 90.84% to $193000.0 in 2025, then plunged by 35.23% to $125000.0 in 2026.
- Business Quant data shows ACHV's Prepaid Assets at $125000.0 in Q1 2026, $193000.0 in Q4 2025, and $1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125,000.00 |
| Dec 31, 2025 | 193,000.00 |
| Sep 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 1.51 Mn |
| Mar 31, 2025 | 1.76 Mn |
| Dec 31, 2024 | 2.11 Mn |
| Sep 30, 2024 | 2.62 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Sep 30, 2023 | 1.90 Mn |
| Jun 30, 2023 | 958,000.00 |
| Mar 31, 2023 | 1.62 Mn |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 2.62 Mn |
| Jun 30, 2022 | 1.46 Mn |
| Mar 31, 2022 | 1.36 Mn |
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 1.27 Mn |
| Jun 30, 2021 | 430,000.00 |